Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHN WILEY & SONS, INC.

(JW.A)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

John Wiley & Sons : More Studies Needed on Mental Health Treatments During and After Pregnancy

05/05/2021 | 01:09am EDT

Untreated mental health disorders can be a serious problem for women and their children during pregnancy and after giving birth, during the postpartum period. A recent analysis funded by the Agency for Healthcare Research and Quality (AHRQ) and published in Psychiatric Research & Clinical Practice notes that few studies have examined the benefits of medications for mental health disorders in pregnant and postpartum women. And while many studies have reported on potential harms, the large majority could not separate the effect of medications from the effect of the underlying disorder. As a result, it is not clear that these medications caused harms to pregnant or postpartum women.

A total of 164 studies were included in the analysis. Study results indicate that brexanolone and sertraline likely lessen depressive symptoms, and mood stabilizers may reduce recurrence of bipolar disorder.

'It's vital for patients and providers to make informed decisions during pregnancy and postpartum, and our study shows a need for more and higher quality research in regards to mental health treatments,' said Meera Viswanathan PhD, of the AHRQ Evidence-based Practice Center at RTI International - University of North Carolina.

Additional Information

Link to Study: https://onlinelibrary.wiley.com/doi/full/10.1176/appi.prcp.20210001

About Journal

Psychiatric Research and Clinical Practice (PRCP) is a new peer-reviewed, open-access journal from the American Psychiatric Association that offers a high-profile publishing destination for submissions that build upon the psychiatric knowledge base and bring research findings closer to clinical utility through deeper investigation.

About Wiley

Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at www.wiley.com.

Disclaimer

John Wiley & Sons Inc. published this content on 05 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 May 2021 05:08:01 UTC.


ę Publicnow 2021
All news about JOHN WILEY & SONS, INC.
05/05JOHN WILEY & SONSá : New Study Identifies Quality Measures for End-of-Life Care ..
PU
05/05JOHN WILEY & SONSá : Many Patients With Cancer Are Experiencing Loneliness and R..
PU
05/05JOHN WILEY & SONSá : Which Medications Are Most Toxic to the Liver?
PU
05/05JOHN WILEY & SONSá : Do Bacteria in the Mouth Affect Risk of Developing Rheumato..
PU
05/05JOHN WILEY & SONSá : Erythropoietin Treatments May Increase Hip Fracture Risk in..
PU
05/05JOHN WILEY & SONSá : How Accurate Are Virtual Assessments of Cognitive Function?
PU
05/05JOHN WILEY & SONSá : The Online Learning Needs of Students Across Different Grad..
PU
05/05JOHN WILEY & SONSá : English as a Medium of Instruction in Higher Education Acro..
PU
05/05JOHN WILEY & SONSá : Light Pollution at Night Affects the Calls of Migratory Bir..
PU
05/05JOHN WILEY & SONSá : New Tool Offers Personalized, Low Environmental Impact, Hea..
PU
More news
Financials (USD)
Sales 2021 1 904 M - -
Net income 2021 139 M - -
Net Debt 2021 938 M - -
P/E ratio 2021 24,9x
Yield 2021 2,22%
Capitalization 3 435 M 3 435 M -
EV / Sales 2021 2,30x
EV / Sales 2022 2,19x
Nbr of Employees 6 900
Free-Float 52,3%
Chart JOHN WILEY & SONS, INC.
Duration : Period :
John Wiley & Sons, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHN WILEY & SONS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 55,33 $
Last Close Price 61,72 $
Spread / Highest target 0,45%
Spread / Average Target -10,3%
Spread / Lowest Target -22,2%
EPS Revisions
Managers and Directors
NameTitle
Brian A. Napack President, Chief Executive Officer & Director
John Anthony Kritzmacher Chief Financial Officer & Executive VP-Operations
Jesse C. Wiley Non-Executive Chairman
Aref Matin Chief Technology Officer & Executive VP
Raymond W. McDaniel Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHN WILEY & SONS, INC.34.17%3 414
S&P GLOBAL INC.15.51%91 465
RELX PLC1.79%49 331
THOMSON REUTERS CORPORATION9.91%46 733
MSCI INC.3.26%38 004
EQUIFAX INC.20.94%28 846